Details of the Drug

General Information of Drug (ID: DMZCW0C)

Drug Name
AP-CDLD
Indication
Disease Entry ICD 11 Status REF
Parkinson disease 8A00.0 Phase 3 [1]
Cross-matching ID
TTD ID
D0S3QH

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)